Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析

◆英語タイトル:Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0357
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Business and Consumer Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Emerald Expositions, Inc. (EEX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Emerald Expositions, Inc (Emerald Expositions) operates business-to-business trade (B2B) shows and conference events. It is an organizer of customer-focused trade shows and other events in the US. The company organizes these trade shows across multiple sectors such as gift, home & general merchandise, sports, design & construction, technology, jewelry; and others including photography, food, healthcare, industrials and military. Its other marketing services consist of print publications and digital media products that complement its trade shows. These events allow various attendees and visitors to interact and engage with several exhibitors and organizers to conduct their purchase and trading activities which in turn builds long-term relationships between various buyers and sellers. Emerald Expositions is headquartered in San Juan Capistrano, California, the US.

Emerald Expositions, Inc. Key Recent Developments

May 03,2018: Emerald Expositions Reports First Quarter 2018 Financial Results
Feb 22,2018: Emerald Expositions Reports Fiscal 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Emerald Expositions, Inc. – Key Facts
Emerald Expositions, Inc. – Key Employees
Emerald Expositions, Inc. – Key Employee Biographies
Emerald Expositions, Inc. – Major Products and Services
Emerald Expositions, Inc. – History
Emerald Expositions, Inc. – Company Statement
Emerald Expositions, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Emerald Expositions, Inc. – Business Description
Emerald Expositions, Inc. – Corporate Strategy
Emerald Expositions, Inc. – SWOT Analysis
SWOT Analysis – Overview
Emerald Expositions, Inc. – Strengths
Emerald Expositions, Inc. – Weaknesses
Emerald Expositions, Inc. – Opportunities
Emerald Expositions, Inc. – Threats
Emerald Expositions, Inc. – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
May 03, 2018: Emerald Expositions Reports First Quarter 2018 Financial Results
Feb 22, 2018: Emerald Expositions Reports Fiscal 2017 Financial Results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Emerald Expositions, Inc., Key Facts
Emerald Expositions, Inc., Key Employees
Emerald Expositions, Inc., Key Employee Biographies
Emerald Expositions, Inc., Major Products and Services
Emerald Expositions, Inc., History
Emerald Expositions, Inc., Subsidiaries
Emerald Expositions, Inc., Key Competitors
Emerald Expositions, Inc., Ratios based on current share price
Emerald Expositions, Inc., Annual Ratios
Emerald Expositions, Inc., Annual Ratios (Cont...1)
Emerald Expositions, Inc., Annual Ratios (Cont...2)
Emerald Expositions, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Emerald Expositions, Inc., Performance Chart (2014 - 2018)
Emerald Expositions, Inc., Ratio Charts

★海外企業調査レポート[Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Progenics Pharmaceuticals Inc (PGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Progenics Pharmaceuticals Inc (Progenics) is a late-stage biopharmaceutical company that focuses on developing medicines and products for the treatment of cancer and related conditions. Its only commercial product, Relistor, is used for the treatment of opioid-induced constipation. The compa …
  • TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TC BioPharm Ltd (TC BioPharm) is an immunotherapy company that develops cell based products for treatment of cancer and viral infection. The company pipeline products are intended for the treatment of ovarian cancer, breast cancer and epidermolysisbullosa related disease, among others. It wo …
  • Caretech Holdings Plc (CTH):企業の財務・戦略的SWOT分析
    Summary Caretech Holdings Plc (CareTech) is a children and adult care service provider. The company offers solution for adults and solution for children and young people. its adult care services includes learning disability, mental health, acquired brain injury, eating disorders, sensory impairments …
  • Banco Pan S.A. (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan S.A. (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Athenex Inc (ATNX)-製薬・医療分野:企業M&A・提携分析
    Summary Athenex Inc (Athenex), formerly Kinex Pharmaceuticals LLC is a drug manufacturing and distributing company that distributes therapies for cancer diseases and supportive therapies. The company offers drug discovery, drug formulation and clinical development. It offers products such as ointmen …
  • Computer Services, Inc (CSVI):企業の財務・戦略的SWOT分析
    Computer Services, Inc (CSVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • China UnionPay Co Ltd:企業の戦略・SWOT・財務分析
    China UnionPay Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China UnionPay Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pets at Home Group Plc (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Group Plc (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • CH. Karnchang Public Company Limited (CK):企業の財務・戦略的SWOT分析
    CH. Karnchang Public Company Limited (CK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Public Broadcasting Service:企業の戦略・SWOT・財務情報
    Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report Summary Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dassault Systemes SA (DSY):医療機器:M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • NTT Data Corporation:企業の戦略・SWOT・財務情報
    NTT Data Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Data Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fiskars Corporation:企業の戦略・SWOT・財務情報
    Fiskars Corporation - Strategy, SWOT and Corporate Finance Report Summary Fiskars Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • illycaffè S.p.A.:企業の戦略・SWOT・財務分析
    illycaffè S.p.A. - Strategy, SWOT and Corporate Finance Report Summary illycaffè S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Hour Glass Ltd (AGS):企業の財務・戦略的SWOT分析
    The Hour Glass Ltd (AGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chang Hwa Commercial Bank, Ltd.:企業の戦略・SWOT・財務分析
    Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Litgrid AB (LGD1L):企業の財務・戦略的SWOT分析
    Litgrid AB (LGD1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Forty Seven Inc (FTSV):製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • BOE Technology Group Co Ltd:企業のM&A・事業提携・投資動向
    BOE Technology Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BOE Technology Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆